Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.

By Jack Cuzick, M. Arbyn, R. Sankaranarayanan, V. Tsu, G. Ronco, M. Mayrand, J. Dillner, C. Meijer. Vaccine, 2008

673 citations recorded by the source corpus.

Subfields: Epidemiology, Surgery

View Paper: https://www.semanticscholar.org/paper/f089df5a86bff231ec3ec75e67ed929a40eca9f5

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. F. Bray
2. J. Ferlay
3. M. Arbyn
4. X. Castellsagué
5. A. Jemal

In Surgery

1. J. Ferlay
2. F. Bray

Citations in the corpus

• Worldwide burden of cervical cancer in 2008. (2011, methodology): “These include one or two HPV tests, in a lifetime followed by visual inspection and cryotherapy of eligible lesions among HPV-positive women for generations already sexually active and completed with immunisation of young girls with an affordable prophylactic HPV vaccine [48].”